You searched for "IOP"
Learnings and trends in the management of open-angle and angle-closure glaucoma
To be truly disruptive, newer technologies need to offer a quality of life benefit over medication to a broad population of glaucoma sufferers. Evidence and converging trends in medical and surgical management of glaucoma were explored in counterpoint discussions and...The eye as a window to the brain: Non-invasive neuromonitoring
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Neuromonitoring, for example in conditions causing raised intracranial pressure (ICP) such as...
Prevalence and risk factors for ROP in Saudi Arabia
This study aimed to establish the prevalence of retinopathy of prematurity (ROP) among high-risk neonates in a tertiary centre, identify the most commonly associated risk factors and highlight the benefits of early treatment of type 2 ROP and ROP milder...100% Optical 2026
WHERE EYEWEAR MEETS EYECAREFirst online education day for locum optometrists
The AOP’s online locum day will take place on Sunday 25 June, 09:30-15:45.Randomisation, confounding & observational methods in ophthalmic epidemiology
Randomisation and confounding Understanding the relationship between an exposure and an outcome of interest is the central challenge in ophthalmic epidemiology. The exposure may be aetiological, taking the form of a putative risk biological factor, or therapeutic, in the form...Eyemate, Big Keys, SeeColors and Lastpass
In this article we are covering four topics, ranging from a service to improve television for the color blind, to an intraocular implant that is now available to measure IOP. SeeColors Samsung have released a new app called SeeColors. The...
Aflibercept for the treatment of neovascular glaucoma
The aim of this study was to investigate initial results regarding the treatment of neovascular glaucoma (NVG) with intravitreal aflibercept. NVG is classified into stages 0-3. In stages 1 and 2, abnormal vessel proliferation is seen with or without elevated...
Sustained elevation of extracellular ATP in chronic glaucoma
Although adenosine 5′-triphosphate (ATP) release from retinal neurons and astrocytes has been demonstrated in short-term increases in intraocular pressure (IOP); such as in aqueous humor of humans with primary acute angle closure glaucoma, the response in chronic IOP elevation was...
Canaloplasty after failed trabeculectomy
The authors describe the technique of canaloplasty performed in five patients who had undergone previous trabeculectomy and under maximum tolerated medical therapy or insufficient intraocular pressure (IOP) control. Canaloplasty is described by the authors as “a nonperforating blebless technique derived...
Nanoparticle administration of latanoprost
Glaucoma is a progressive optic neuropathy characterised by increased ocular pressure and loss of retinal ganglion cells. Conventional drug therapy with eye drops to reduce intraocular pressure (IOP) has variable bioavailability and can lead to ocular surface disease. In this...
